BOXIDRA Trademark

Trademark Overview


On Tuesday, July 16, 2013, a trademark application was filed for BOXIDRA with the United States Patent and Trademark Office. The USPTO has given the BOXIDRA trademark a serial number of 86012047. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 14, 2023. This trademark is owned by Glaxo Group Limited. The BOXIDRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculo...
boxidra

General Information


Serial Number86012047
Word MarkBOXIDRA
Filing DateTuesday, July 16, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 14, 2023
Registration Number5111833
Registration DateTuesday, January 3, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "BOXIDRA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, July 14, 2023CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 3, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 3, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, November 29, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, November 21, 2016NOTICE OF ALLOWANCE CANCELLED
Monday, November 21, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 16, 2016SOU EXTENSION 5 GRANTED
Wednesday, June 29, 2016SOU EXTENSION 5 FILED
Wednesday, June 29, 2016SOU TEAS EXTENSION RECEIVED
Friday, January 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 7, 2016SOU EXTENSION 4 GRANTED
Monday, December 21, 2015SOU EXTENSION 4 FILED
Monday, December 21, 2015SOU TEAS EXTENSION RECEIVED
Saturday, June 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 26, 2015SOU EXTENSION 3 GRANTED
Saturday, May 23, 2015SOU EXTENSION 3 FILED
Tuesday, June 23, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 22, 2015SOU EXTENSION 2 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 2 FILED
Thursday, January 22, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 2, 2014SOU TEAS EXTENSION RECEIVED
Saturday, July 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 17, 2014SOU EXTENSION 1 GRANTED
Thursday, July 17, 2014SOU EXTENSION 1 FILED
Thursday, July 17, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, January 21, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 18, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 17, 2013ASSIGNED TO EXAMINER
Tuesday, July 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 19, 2013NEW APPLICATION ENTERED